- Datum11.09.2024
- Uhrzeit15:00 - 15:30 Uhr
- Veranstalter
stock3
Du willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnen![stock3 Terminal Chart](/img/banner/chart-light.png)
Bio-Rad Laboratories Inc. Kurse
Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
---|---|---|---|---|---|---|
NYSE | VK | |||||
L&S | VK | |||||
Tradegate | VK |
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (NYSE)
Wikifolio
Passender Service zu Bio-Rad Laboratories Inc.
Webinar zu Bio-Rad Laboratories Inc.
Kursinformationen (NYSE)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)261,590-384,370
- Jahrestief / Hoch ($)262,120-364,240
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Bio-Rad Laboratories Inc.
Termine von Bio-Rad Laboratories Inc.
- Okt24Bio-Rad Laboratories Inc.Q3 2024 Earnings Release
- Feb13Bio-Rad Laboratories Inc.Q4 2024 Earnings Release
- Apr24Bio-Rad Laboratories Inc.Q1 2025 Earnings Release
Beschreibung
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.